Last reviewed · How we verify
NCT04411004: ENDO-SHAVING
Persistence Disease After Laparoscopic Shaving of Rectal Endometriosis
trial testing Transvaginal ultrasound in Endometriosis, Rectum in 100 participants. Completed in 1 January 2020.
30 November 2019
Quick facts
| Lead sponsor | Ospedale Policlinico San Martino |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 May 2017 |
| Primary completion | 30 November 2019 |
| Estimated completion | 1 January 2020 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Transvaginal ultrasound
- 5-point Likert scale
Conditions studied
- Endometriosis, Rectum — all drugs for Endometriosis, Rectum →
Sponsor
Ospedale Policlinico San Martino
Who can join
18 and older, female only, with Endometriosis, Rectum. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
When performing shaving of a rectal endometriotic nodule, the surgeon can use the macroscopic appearance of the nodule and the tactile feedback provided by the laparoscopic instruments to decide the area of the bowel that needs to be excised. Theoretically, compared with segmental bowel resection, the shaving technique may expose the patients to a higher risk of persistence of intestinal endometriosis. The objective of this ultrasonographic study was to assess the risk of rectal endometriosis persistence following laparoscopic shaving of rectovaginal nodules.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04411004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transvaginal ultrasound
Trials testing the same drug.
- NCT07114705 — The Relationship Between the Number of Ceserean Sections and Scar Niche Development · not yet recruiting
- NCT06968364 — FB-CT2 Includes Two Prospective, Multi-centre Studies With a Medical Device in Hospital Settings: a Randomized, Dual-arm · NA · recruiting
- NCT07264933 — Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation · NA · completed
- NCT06828536 — Female Genital Schistosomiasis in Migrant Women: A Pilot Study · NA · not yet recruiting
- NCT06041347 — Learning Curve for the Visualization of Sacral Plexus on TVS · unknown
Other recruiting trials for Endometriosis, Rectum
Currently open trials in the same condition.
- NCT04204707 — Patient Reported Outcomes After Surgery for Rectal Endometriosis · active not recruiting
Other Ospedale Policlinico San Martino trials
Trials by the same sponsor.
- NCT07029620 — Peripheral Neuropathy Rehabilitation With Stabilometric Platforms (NEUROSTAB) · NA · not yet recruiting
- NCT07235111 — Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases · recruiting
- NCT06809673 — PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial · enrolling by invitation
- NCT06274580 — Endovascular vs Conservative Treatment in Patients With Chronic Subdural Hematomas and Mild Symptoms · NA · unknown
- NCT07061093 — Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observationa · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04411004 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ospedale Policlinico San Martino
- Last refreshed: 18 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04411004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing